Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Autoimmune Diseases
>>
Immune Checkpoint Inhibitors
>>
Phase 1
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
prezalumab
(AMG 557) / Amgen, AstraZeneca
dapirolizumab pegol
(CDP7657) / Biogen, UCB, Nektar Therap
MEDI-570
/ AstraZeneca